The DNA damage response (DDR) is a highly orchestrated process but how double-strand DNA breaks (DSBs) are initially recognized is unclear. Here, we show that polymerized SIRT6 deacetylase recognizes DSBs and potentiates the DDR. First, SIRT1 deacetylates SIRT6 at residue K33, which is important for SIRT6 polymerization and mobilization toward DSBs. Then, K33-deacetylated SIRT6 anchors to γH2AX, allowing its retention on and subsequent remodeling of local chromatin. We show that a K33R mutation that mimics hypoacetylated SIRT6 can rescue defective DNA repair as a result of SIRT1 deficiency in cultured cells. These data highlight the synergistic action between SIRTs in the spatiotemporal regulation of the DDR and DNA repair.
Introduction
DNA damage can be induced by various endogenous and exogenous agents. Upon detection of damage, the DNA damage response (DDR) is immediately elicited to regain genomic integrity via chromatin remodeling, signaling transduction and amplification (1) . Double-strand breaks (DSBs) are the most severe type of DNA lesion; they are recognized by the Mre11-Rad50-Nbs1 (MRN) complex, which recruits and activates phosphatidylinositol 3-kinase-like protein kinase ataxia-telangiectasia mutated (ATM) or ATM-and Rad3-related (ATR). H2AX is then rapidly phosphorylated (γH2AX) by ATM/ATR, and serves as a platform to localize repair proteins near to the DNA breaks (2) . Simultaneously, various histone-modifying enzymes, heterochromatin factors and ATP-dependent chromatin remodelers work cooperatively to relax the chromatin structure and ensure that additional repair factors have access to the DSBs (3) . Despite all these advances in understanding the DDR, how DSBs are initially and precisely recognized is largely unknown.
NAD + -dependent sirtuins belong to class III histone deacetylases (HDACs) (4) . Seven sirtuins (SIRT1-7) with various enzymatic activities and physiological functions are expressed in mammals. SIRT1, 6 and 7 localize in the nucleus and seem to be most relevant to the DDR as their depletion causes growth retardation, a defective DDR and DNA repair and premature aging (5) (6) (7) . Upon DNA damage, SIRT1 redistributes on chromatin, co-localizes with γH2AX, and deacetylates XPA, NBS1 and Ku70 to regulate nucleotide excision repair, homologous recombination (HR) and non-homologous end-joining (NHEJ) (8) (9) (10) (11) . Depleting Sirt1 in mouse fibroblasts impairs the DDR and leads to genomic instability (6) . SIRT6 is one of the earliest factors recruited to DSBs; it initiates the subsequent recruitment of SNF2H, H2AX, DNA-PKcs and PARP1 (12) (13) (14) (15) . SIRT6 mono-ribosylates PARP1 to enhance its activity (16) . Despite their rapid mobilization to DNA breaks, the triggers for sirtuin recruitment are obscure (7, 17, 18) .
Here, we aimed to delineate the mechanisms underlying DSB recognition. We found that SIRT6 polymerizes and directly recognizes DSBs via a putative DNA-binding pocket consisting of N-and C-termini from two adjacent molecules. SIRT1 interacts with SIRT6 and deacetylates it at K33, thus allowing its polymerization and recognition of DSBs. A K33R mutant, mimicking hypoacetylated SIRT6, could rescue DNA repair defects in SIRT1 knockout (KO) cells. Our data highlight an essential synergy between SIRT1 and SIRT6 in the spatiotemporal regulation of the DDR.
Results

SIRT6 directly recognizes DNA double-strand breaks
Nuclear SIRTs (SIRT1/6/7) are quickly mobilized to DSBs ( Figure S1 ) and serve as a scaffold for DNA repair factors (7, 17, 18) . Intriguingly, these nuclear SIRTs are also activated by RNA and the nucleosome (19, 20) . We thus reasoned that SIRTs might directly sense DNA breaks, especially DSBs. To test our hypothesis, we established a molecular docking simulation using AutoDock Vina software (21) . We obtained crystal structures for SIRT1 (PDB code 4I5I) (22) , SIRT6 (PDB code 3PKI) (23) and SIRT7 (PDB code 5IQZ) (24) from the Protein Data Bank (https://www.rcsb.org). We removed the heteroatoms and added Gasteiger charges to the atoms. A DSB structure was extracted from the PDB code 4DQY (25) . As SIRTs use NAD + as a co-substrate in amide bond hydrolysis, which shares a similar skeleton to the phosphate, base and ribose groups on broken DSB ends, we included NAD + as a simulation control.
We found that the binding affinity between NAD + and all nuclear SIRTs was within the range of -8 to -10 kcal/mol ( Figure 1A) . Surprisingly, only the binding between the DSB and SIRT6 was energetically favored (-12.7 kcal/mol), being even lower than that of NAD + (Figures 1A,B ). This finding suggested that SIRT6 might directly bind to DSBs and prompted us to gain further experimental evidence.
We next generated a DSB-mimicking biotin-conjugated DNA duplex and performed an in vitro pulldown assay. Recombinant SIRT6 (rSIRT6), but not rSIRT1 or rSIRT7, bound to the DNA duplex ( Figure 1C ). This finding was verified by a fluorescence polarization (FP) assay using a FAM-labeled DNA duplex. Here, we observed dynamic FP (Kd = 166.3 nM; Figure 1D ), supporting a specific and direct interaction between the DNA duplex and rSIRT6. By contrast, the FP was minimal for both rSIRT1 and rSIRT7 ( Figure 1D ). To interrogate whether such binding is specific to broken DNA, we repeated the pulldown assay in the presence of unlabeled linear or circular DNA. While linearized DNA inhibited rSIRT6 binding to the DNA duplex, circular DNA had a minimal effect ( Figure 1E ). Together, these data indicate that SIRT6, but not SIRT1 or SIRT7 recognizes and directly binds to DSBs. 
SIRT6 is dynamically acetylated in the N terminus at K33
As predicted from the crystallographic data, SIRT6s form an asymmetric hexamer (23) that generates three potential DSB binding pockets; each of these pockets consist of two N-termini and two C-termini from two adjacent molecules ( Figure S2A ). Both the N-termini and C-termini are essential for SIRT6 to associate with chromatin (26) . To gain biochemical evidence for SIRT6 polymerization, we used a biomolecule fluorescence compensation system (BiFC). In brief, we cloned SIRT6 cDNA into either the N-terminal or C-terminal of a yellow fluorescence protein (YFP), herein termed N-SIRT6 and C-SIRT6. The yellow fluorescence was detectable by FACS only when N-SIRT6 directly interacted with C-SIRT6. After co-transfecting these constructs into HEK293 cells, we detected a strong fluorescence signal by FACS in >24% cells ( Figure S2B ), suggesting a direct interaction between the two SIRT6 molecules. To confirm this SIRT6 polymerization event, we performed a co-immunoprecipitation (Co-IP) assay in HEK293 cells in which we had co-overexpressed FLAG-SIRT6 and HA-SIRT6. Consistently, we detected FLAG-SIRT6 in the anti-HA-SIRT6 immunoprecipitates ( Figure S2C ).
The DSB phosphate backbone is negatively charged. The positive-charged environment of SIRT6 thus favors its binding to DSBs. Indeed, one of our predicted DSB-binding pockets formed by two adjacent molecules in SIRT6 hexamer consisted of six positively charged residues at the edge, namely four arginine (R32/39) and two lysine (K33) residues ( Figure S2D ). Acetylation is the most redundant post-translational modification that converts positively charged K to neutral Kac. This property is utilized by proteins with a lysine-rich domain (KRD), e.g. Histones, Ku70 and p53, for mediating dynamic interactions with proteins harboring an acidic domain like SET (27) . The heterodimerized Ku70 and Ku80 complex directly senses DSBs via a flexible C-termini containing multiple K residues, and regulates NHEJ (28) . We therefore examined whether SIRT6 is (de)acetylated on these K residues thus sensing DSBs. We immunoprecipitated FLAG-SIRT6 with an anti-FLAG antibody and then probed the immunoprecipitate with anti-Kac antibodies. As shown, Kac was detected in the precipitated FLAG-SIRT6 immunocomplex (Figure 2A ). We then purified FLAG-SIRT6 and performed high-resolution LC-MS/MS to identify which K residues are acetylated (Table S1 ). We identified K15 and K33 in the N-terminus. To confirm these acetylated K residues, we generated K15R and K33R point mutants, with K17R serving as a negative control. While neither K15R nor K17R affected the FLAG-SIRT6 acetylation level, K33R significantly inhibited it (Figures 2A and S3 ), supporting that K33 is dynamically (de)acetylated.
Dynamic SIRT6 K33 (de)acetylation regulates DSB sensing
To understand the function of SIRT6 K33 acetylation, we examined whether it is required for binding to DSBs. We used our K33R mutant and generated a new K33Q mutant to mimic deacetylated or acetylated SIRT6, respectively (29) . We also mutated SIRT6 H133 to a tyrosine residue (H133Y) to blunt SIRT6 enzymatic activity (18) .
K33Q and H133Y binding to the DNA duplex was significantly compromised compared to WT and K33R binding ( Figure 2B ). Consistently, we recorded notable FP for SIRT6 K33R (Kd = 104.9 nM) but hardly any FP for SIRT6 K33Q ( Figure 2C ).
We then monitored GFP-SIRT6 mobility in cells upon receipt of DNA damage. H133
is critical for enriching SIRT6 on chromatin (26) . We reconstituted GPF-SIRT6 WT, K33Q, K33R and H133Y in Sirt6 -/cells and monitored their recruitment to DSBs.
While the K33Q and H133Y mutations significantly jeopardized efficient SIRT6 recruitment to DNA breaks, the SIRT6 K33R mutant retained such ability (Figures 2D-E). To gain more experimental support, we made use of an inducible DR-GFP reporter system that contains a unique I-SceI cutting site. In presence of triamcinolone acetonide (TA), the I-SceI-GR enzyme translocates to the nucleus within 10 min and generates DSBs, as evidenced by an increase in the γH2AX level ( Figure 2F -G). We thus monitored the occupancy of SIRT6 on chromatin surrounding these induced DSBs, by chromatin immunoprecipitation (ChIP) and quantitative PCR, as previously described (30) . Both the K33Q and H133Y mutations compromised SIRT6 recruitment to the sites of damage, whereas SIRT6 K33R recruitment was comparable to that of SIRT6 WT (Figures 2H).
Upon DNA damage, the acetylation levels of H3K9 and H3K56 decline, and after repair, goes back to the original level (31) . H3K9ac and H3K56ac are deacetylating targets of SIRT6, indicating that SIRT6 might contribute to the reduced H3K9ac and H3K56ac levels on the DSB-surrounding chromatin. Indeed, reconstituted SIRT6 WT and K33R downregulated the levels of H3K9ac and H3K56ac in Sirt6 -/cells, while K33Q and H133Y failed ( Figures 2I and S4A ). Further, the K33Q and H133Y mutations also affected SNF2H recruitment to DSBs ( Figure S4B ), which requires SIRT6 (18), but no effect was observed in the presence of the K33R mutation. Of note, neither K33R nor K33Q affected the deacetylase activity of SIRT6 ( Figure S4C ). We next analyzed whether dynamic K33 (de)acetylation modulates SIRT6 polymerization. We co-overexpressed HA-SIRT6 and various FLAG-SIRT6 mutants and performed a Co-IP assay. We detected FLAG-SIRT6 in the anti-HA immunoprecipitates, supporting that SIRT6 polymerization occurs ( Figure S2C ).
While HA-SIRT6 bound to SIRT6 K33R to a similar extent as to SIRT6 WT, its binding to SIRT6 K33Q was significantly jeopardized. Of note, the enzyme-dead H133Y mutation also jeopardized SIRT6 polymerization. This finding is consistent with the fact that the H133 site is important for both SIRT6 deacetylase activity and for mediating the chromatin association (26) . We confirmed this jeopardized polymerization in the K33Q mutant condition by BiFC assay (Figure S5A,B ).
Together, these data implicate that dynamic SIRT6 K33 (de)acetylation modulates SIRT6 polymerization and thus DSB binding. 
SIRT6 interacts with SIRT1
Having confirmed SIRT6 (de)acetylation, we moved to examine potential deacetylase of SIRT6. To this end, we first tested the effect of various HDAC inhibitors on SIRT6 acetylation level. We noticed that the level of acetylated SIRT6 was largely elevated in the presence of the class III HDAC (SIRTs) inhibitor nicotinamide (NAM) or the SIRT1-specific inhibitor Ex527, but not the class I/II HADC inhibitor Trichostatin A (TSA) ( Figure S6 ). This finding suggested that SIRT1 might be involved in SIRT6 deacetylation. Indeed, co-IP and western blotting revealed that FLAG-SIRT6 interacted with endogenous SIRT1 ( Figure 3A ) and vice versa in HEK293 cells ( Figure 3B ). In addition, we detected SIRT1 in the anti-SIRT6 immunoprecipitates and vice versa ( Figure 3C,D) . A GST pulldown assay confirmed that His-SIRT1 directly interacted with GST-SIRT6 ( Figure 3E ). Further, we observed co-localization between SIRT6 and SIRT1 by confocal microscopy in cells co-transfected with GFP-SIRT6 and DsRed-SIRT1 or in cells co-stained with specific antibodies ( Figures   3F and S7A ).
SIRTs contain a conserved Sir2 domain and flexible N-termini and C-termini. To locate the exact SIRT6 domains that interact with SIRT1, we deleted the N-terminus and C-terminus, as previously reported (26) (Figure S7B ,C). Western blotting analysis showed that the interaction between SIRT6 and SIRT1 was lost if the N-terminus or C-terminus of SIRT6 was deleted ( Figure 3G ). As the C-terminus contains the nuclear location signal (26) , we speculate that its depletion may restrict SIRT6 in cytoplasm, thus preventing the interaction between SIRT1 and SIRT6. Thus, the data indicate that SIRT6 physically interacts with SIRT1, most likely through the N-terminus of SIRT6. 
SIRT1 deacetylates SIRT6 at K33
We next examined whether SIRT1 deacetylates SIRT6 via the direct interaction that we identified above. Overexpression of SIRT1 but not of other sirtuins inhibited FLAG-SIRT6 acetylation ( Figure 4A ). Conversely, knocking down SIRT1 significantly upregulated endogenous SIRT6 acetylation in HEK293 cells ( Figure 4B ). Furthermore, the SIRT6 acetylation level decreased in the presence of ectopic SIRT1 but not in the presence of its catalytic mutant SIRT1-H363Y ( Figure 4C ), despite the two proteins still showing a physical interaction, suggesting that SIRT6 is likely a deacetylation target of SIRT1. To test our hypothesis, we established an in vitro deacetylation assay. We eluted recombinant FLAG-SIRT6 with a FLAG peptide from HEK293 cell lysate. We found that SIRT1 deacetylated SIRT6 in the presence of NAD + , while NAM inhibited this process ( Figure 4D ). The deacetylase-inactive SIRT1-H363Y was unable to deacetylate SIRT6.
As SIRT1 might interact with the SIRT6 N-terminus, we hypothesized that it might also deacetylate K33ac. While the acetylation level of SIRT6 was increased in SIRT1 -/-HEK293 cells, that of K33R was hardly affected ( Figure 4E ). Additionally, the acetylation level of SIRT6 K33R was minimally changed upon SIRT1 overexpression ( Figure 4F ), whereas that of K143/145R was downregulated upon ectopic SIRT1 ( Figure S8A ). These data support that K33ac is a target of SIRT1. By contrast, the SIRT1 acetylation level was relatively unaffected upon SIRT6 overexpression ( Figure S8B ). To further validate these findings, we synthesized a K33ac-containing peptide, and found that it effectively blocked the in vitro binding of SIRT6 to SIRT1 ( Figure 4G ). Of note, the GST pulldown assay suggested that the N-terminus rather than the C-terminus of SIRT6 was responsible for its interaction with SIRT1. Together, these data suggest that SIRT1 deacetylates SIRT6 at K33. γH2AX ensures SIRT6 retention surrounding DSBs γH2AX is dispensable for initial DSB recognition but serves as a platform for recruiting DDR factors (2) . Because SIRT6 is enriched at DNA breaks, we next asked whether γH2AX is involved in SIRT6 recruitment. We thus performed a co-IP of endogenous SIRT6 in cells treated with or without camptothecin (CPT). Interestingly, H2AX and γH2AX were detected in the anti-SIRT6 precipitates only when the cells were treated with CPT ( Figure 5A,B) . We also performed an in vitro pulldown assay with a biotin-labeled C-terminal γH2AX peptide or H2AX peptide. Consistently, GST-SIRT6 recognized the γH2AX peptide but not the H2AX peptide ( Figure 5C ). To identify the interacting domain, we purified various GST-SIRT6 truncation mutants.
Peptide pulldown assay revealed that the N-terminus truncation was enough to abolish SIRT6 binding to γH2AX peptide, while the C-terminus truncation had a minimal effect ( Figure 5D ). We then investigated whether SIRT1-mediated deacetylation contributes to SIRT6 binding to γH2AX. Here, the K33R mutant efficiently bound to γH2AX to a similar extent as WT SIRT6, but the binding was abolished in the case of K33Q ( Figure 5E ).
To investigate the functional relevance of this SIRT6-γH2AX interaction, we applied laser-induced DNA damage in MEFs lacking H2AX and then tracked the distribution of SIRT6 by immunofluorescence microscopy. GFP-SIRT6 was immediately recruited to DNA lesions in H2AX +/+ and H2AX −/− MEFs ( Figure 5F ), implying that H2AX is dispensable for initial SIRT6 recruitment of SIRT6. Interestingly, GFP-SIRT6 diminished from DNA lesions at 10 min after laser treatment in H2AX -/-MEFs but persisted in H2AX +/+ cells. H2AX is rapidly phosphorylated at serine 139 in response to DSBs (32) . When we re-introduced H2AX WT, S139A and S139D into H2AX -/-MEFs, SIRT6 retention was restored in WT and S139D-re-expressing cells but not in S139A-re-expressing cells ( Figure 5G ). Together, these data indicate that SIRT6 recognizes γH2AX surrounding DSBs and that this recognition is enhanced by SIRT1-mediated deacetylation. (E) Pulldown assay and western blot analysis of the interactions between the γH2AX peptide and GST-SIRT6 WT, K33R and K33Q.
(F,G) Laser MicroPoint analysis of SIRT6 recruitment in H2AX +/+ and H2AX -/-MEFs (F), and in H2AX -/-MEFs reconstituted with H2AX WT, S139D mimicking hyper-phosphorylation or S139A mimicking hypo-phosphorylation (G). PAR immunostaining was used to identify the DNA damage site.
SIRT1 and SIRT6 cooperatively promote DNA repair
The physical interaction between SIRT1 and SIRT6 prompted us to investigate whether SIRT1 and SIRT6 cooperatively modulate the DDR and DNA repair. To do so, we combined the DR-GFP reporter system with a ChIP-PCR analysis. First, we found that FLAG-SIRT6 recruitment to the DSB vicinity was significantly reduced when SIRT1 was silenced by siRNA in HEK293 cells (Figures 6A,B ). Then we monitored the dynamic recruitment of GFP-SIRT6 upon laser-induced DNA damage using a MicroPoint system. GFP-SIRT6 was rapidly recruited to DSBs in WT cells, 
SIRT6 rescues DNA repair defects caused by SIRT1 deficiency
In our final set of assays, we wanted to determine the function of SIRT6 deacetylation in DNA repair. We found that SIRT6 acetylation was significantly decreased upon CPT treatment, but that the effects of CPT were abolished in the presence of SIRT6 K33R or in the absence of SIRT1 ( Figure 7A ). These data imply that SIRT6 is deacetylated by SIRT1 upon DNA damage. We then examined the effects of the SIRT6 mutants on DNA repair by comet assay, which assesses the DNA repair ability at the single cell level. We overexpressed SIRT6 K33R or K33Q in SIRT6 -/cells and then examined the DNA repair efficacy. Here, overexpression of SIRT6 significantly enhanced DNA repair efficacy upon CPT treatment, while K33Q or H133Y lost the ability. By contrast, SIRT6 K33R overexpression promoted DNA repair to an extent comparable to WT ( Figure 7B ). An HR assay showed that SIRT6 WT and K33R but neither K33Q nor H133Y enhanced HR capacity ( Figure 7C ). Furthermore, compared to SIRT6 WT and K33R, K33Q significantly inhibited the colony forming capacity of transfected Hela cells ( Figure 7D ). Upon ionized radiation, while both SIRT6 WT and K33R enhanced cell survival, K33Q and H133Y inhibited it ( Figure 7E ). These data implicate that SIRT6 deacetylation at K33 is indispensable for DNA repair. SIRT1 regulates DNA repair (6) . To elucidate the synergistic effects of SIRTs in DNA repair, we examined whether SIRT6 hyper-acetylation is responsible for the defective DNA repair capacity seen in SIRT1 -/-HEK293 cells. SIRT6 WT, K33R and SIRT1 overexpression rescued the defective DNA repair imposed by the SIRT1 deficiency, while SIRT6 K33Q and H133Y had minimal rescue effect ( Figure 7F ). Altogether, these data implicate a synergistic action between SIRT1 and SIRT6 in regulating the DDR and DNA repair. We thus propose a model by which SIRT6 is deacetylated by SIRT1 at K33, thus promoting its polymerization and recognition of DSBs; SIRT6 that is deacetylated at K33 anchors to γH2AX, allowing retention on the chromatin flanking the DSBs and subsequent remodeling via deacetylating H3K9ac and H3K56ac ( Figure 7G ). 
Discussion
The DDR is a highly orchestrated process that is initiated by DNA break-sensing (1) .
While the MRN complex (33) , Ku complex (28) , RPA (34) and PARP1 (35, 36) are all known to directly recognize DSBs, sirtuins are among the earliest factors to be recruited to DSBs (17, 18) and facilitate PARP1 recruitment (7) . Consistent with published data (23), we found that SIRT6 oligomerizes and recognizes DSBs via a DSB-binding pocket generated by the N-termini and C-termini of two adjacent molecules. This finding is consistent with another report showing that both the N-termini and C-termini are essential for the chromatin association of SIRT6 (26) .
Using a super-resolution fluorescent particle tracking method, Yang et al. recently found that PARP1 binding to DSBs happens earlier than SIRT6 binding (37) . One possible explanation is that PARP1 is first recruited to DSBs; then, SIRTs are later recruited directly by DSBs and facilitate PARP1 stabilization and expansion in the surrounding region.
The sirtuin family members share similar functions in the DDR and in DNA repair; upon DNA damage, both SIRT1 and SIRT6 are rapidly mobilized to DSBs (7, 17, 18) . SIRT1 redistributes on chromatin and deacetylates XPA, NBS1 and Ku70 to promote DNA repair (8) (9) (10) (11) . SIRT6 mono-ribosylates PARP1 to enhance its activity (16) , and facilitates the subsequent recruitment of SNF2H, H2AX and DNA-PKcs (12) (13) (14) (15) .
Here we revealed a synergistic action between two nuclear SIRTs, whereby SIRT1 deacetylates SIRT6 to promote its mobilization to DSBs. A SIRT6 K33R mutant, mimicking hypo-acetylated SIRT6, can rescue DNA repair defects in SIRT1 null cells.
Interestingly, SIRT6 phosphorylation at S10 by JNK promotes subsequent recruitment itself and PARP1 upon oxidative stress, also supporting an essential role of the SIRT6 N terminus for DSB-recruitment (15) . Consistent with the cooperative action between SIRT1 and SIRT6, independent studies have revealed an interaction between SIRT1 and SIRT7, showing that SIRT1 recruits SIRT7 to promote cancer cell metastasis (38) , and that SIRT1 and SIRT7 antagonistically regulate adipogenesis (39) .
The acetylation levels of H3K9 and H3K56 decrease upon detecting DNA damage and then return to basal levels (31) . SIRT1 and SIRT6 are H3K9ac and H3K56ac deacetylases; both are recruited to DSBs upon DNA damage, indicating that SIRT1 and/or SIRT6 might contribute to reducing H3K9ac and H3K56ac levels. Although mechanistically unclear, H3K9ac and H3K56ac levels negatively correlate with γH2AX levels (40) . In this study, we found that while γH2AX is not required for initial SIRT6 recruitment, it is indispensable for retaining SIRT6 on the local chromatin surrounding DSBs. This finding is consistent with reports that γH2AX is dispensable for initial reorganization of DNA breaks but rather serves as a platform to stabilize repair factors, such as NBS1, 53BP1 and BRCA1 (2). SIRT6 deacetylates H3K9ac and H3K56ac surrounding DSBs, in this way bridging γH2AX to chromatin remodeling. Together, these findings provide a scenario as to how γH2AX and histone modifiers coordinate to amplify the DDR. SIRT6 and SNF2H cooperate to stabilize γH2AX foci (41) . Here we found that γH2AX in-fact anchors SIRT6 to DSBs, providing a positive feedback regulatory loop between SIRT6 and γH2AX. This finding is consistent with reports showing a distinct reduction of γH2AX and an improper DDR in Sirt6 -/and Sirt1 -/cells. Recent work also suggests that an electrostatic force between a negatively charged phosphate group and a positively charged lysine groups is a novel form of protein-protein interaction (27) . We thus consider it plausible to speculate that (de)acetylation might act as a switch to modulate such an interaction between SIRT6 and γH2AX.
Known as longevity-associated genes, SIRT6 and SIRT1 are redundant in DNA repair but not replaceable. In this study, we have identified that SIRT6 directly binds to DNA breaks and have elucidated a physical and functional interaction between SIRT6 and SIRT1. SIRT6 rescues DNA repair defects imposed by SIRT1 deficiency. Overall, these data highlight a synergistic action of nuclear SIRTs in the spatiotemporal regulation of the DDR and DNA repair.
Materials and Methods
Antibodies, Oligos and Plasmids
The commercial antibodies used in this study included: SIRT6, SNF2H, pan-AcK, H3 and γH2AX (Abcam), H2AX, SIRT1 and GST (CST), H3K9ac and H3K56ac (Millipore), SIRT6 (Novus), Tubulin and FLAG (Sigma).
The following oligos (Genewiz) were used for RNA interference: Human SIRT6 was cloned into pCDNA3.1 with a FLAG tag (Invitrogen, USA); a 3×FLAG-SIRT1 and DR-GFP plasmids were obtained from Addgene. SIRT6ΔC and ΔN were amplified with specific primers and cloned into pKH3HA (Addgene) and pGex vectors (GE Healthcare Life Sciences). The SIRT6 KR, KQ and HY mutants were obtained by converting SIRT6 lysine 33 to arginine (KR), or to glutamine (KQ) and SIRT6 133 histidine to tyrosine (HY) via site-directed mutagenesis, as described below.
Site-directed mutagenesis
The primers used for mutagenesis were designed using the online Quick Change DpnI endonuclease for 1 h at 37°C, before transformation and sequencing.
The following primers were used to generate the SIRT6 KR, KQ and HY mutants: 
Chromatin Immunoprecipitation (ChIP)
I-SceI-GR assays were performed as previously described (30) . Hela cells stably transfected with DR-GFP were transiently transfected with RFP-I-SceI-GR together with FLAG-SIRT6, KR, KQ or HY. The cells were treated with 10 -7 M triamcinolone acetonide (TA, Sangon, Shanghai) for 20 min, 48 h after transfection, and then fixed with 1% paraformaldehyde at 37°C for 10 min to crosslink the chromatin. The reaction was stopped upon the addition of 0.125 M glycine. The chromatin was sonicated to 200 bps~600 bps and incubated with the indicated antibodies. After de-cross linking, the ChIP-associated DNA was isolated and analyzed by quantitative real-time PCR (qRT-PCR).
Comet assay
A comet assay was performed as previously described (42) . Briefly, after CPT treatment, the cells were digested into a single cell suspension, mixed with 1% agarose at the density of 1 × 10 5 , coated on the slide and then incubated in lysis buffer (2% sarkosyl, 0.5M Na2EDTA, 0.5 mg/ml proteinase K) overnight at 37℃. The slides were incubated with N2 buffer (90 mM Tris, 90 mM boric acid and 2 mM Na2EDTA) and subjected to electrophoresis for 25 min at 0.6 V/cm. The slides were then incubated in staining solution containing 2.5 μg/ml propidium iodide for 30 min at room temperature. Images were captured under a fluorescent microscope.
Cell fractionation
Cells were scraped and washed with cold PBS. The cell pellet was resuspended in nuclei lysis buffer (10 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 0.34M sucrose, 10% glycerol, 1mM DTT, 0.1% TrionX-100.) for 10 min on ice and then centrifuged at 1300 g for 10 min. The pellet was resuspended in lysis buffer (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT) for 10 min on ice and centrifuged at 1700 g for 10 min. The pellet was saved as the chromatin fraction. Briefly, a pX459 vector (Addgene#48139) was digested with BbsI and ligated with annealed oligonucleotides. The constructs containing the target gRNAs were transfected into HEK293T cells with Lipofetamine3000® (Invitrogen). The cells were selected for 5 days with puromycin 24 h after transfection. Single clones were picked for sequencing.
MicroPoint® laser irradiation and microscopy
Peptide pulldown assay
The C termini of H2AX (BGKKATQASQEY) and γH2AX (BGKKATQApSQEY)
were synthesized and conjugated with biotin (GL Biochem, Shanghai). For one reaction, 1 μg biotinylated peptides was incubated with 1 μg GST-SIRT6 in binding buffer (50 mM Tirs-HCl, 200 mM NaCl, 0.05% NP40) overnight at 4°C. Streptavidin Sepharose beads (GE) was then used to pulldown the peptide and protein complexes for 1 h at 4°C, and the samples were analyzed by western blotting.
Immunofluorescence staining
The cells were washed with PBS and fixed with 4% formaldehyde for 20 min, followed by permeabilization with cold methanol (-20°C) for 5 min and blocking with 5% BSA for 30 min. Then, the cells were incubated with primary antibodies (SIRT1, 1:200 dilution in 1% BSA; γH2AX, 1:500 dilution in 1% BSA; SIRT6, 1:200 dilution in 1% BSA) for 1 h and secondary antibodies (donkey anti-rabbit IgG Alexa Fluor 594 and donkey anti-mouse IgG FITC from Invitrogen, 1:500 dilution in1% BSA) for 1 h at room temperature in the dark. The cells were then co-stained with DAPI (Invitrogen) and observed under a fluorescent microscope.
HR assay
U2OS cells stably transfected with DR-GFP were transfected with HA-I-SceI together with Flag-SIRT6 WT, K33R, K33Q or HY. After transfection for 48 h, the cells were harvested and the GFP positive cell ratio per 10 4 cells was analyzed by flow cytometry (BD Biosciences). The relative HR efficiency was normalized to the vector control.
Colony formation assay
Hella cells were seeded into six-well plates 24 h after transfection in defined numbers.
Then, 24 h after re-plating, the cells were exposed to increasing amounts of ionizing radiation delivered by an X-Rad 320 irradiator (Precision X-Ray Inc. N. Branford, CT, USA). Fresh media was added after 7 days. Colonies containing at least 50 cells (10-14 days) were fixed with 20% methanol and stained with crystal violet and analyzed.
DNA pulldown assay
The DNA binding assay was performed as previously described (43) . Briefly, a biotin-conjugated DNA duplex 220 bp in size was generated by PCR amplification using biotin-labeled primers and a I-SceI plasmid as a template.
For the DNA pulldown assay, 10 pmol biotinylated DNA duplex was incubated with 0.5 μg of the indicated recombinant proteins in 300 μl binding buffer (10 mM Tris-Cl pH7.5, 100 mM NaCl, 0.01% NP40 and 10% glycerol) overnight at 4°C. Streptavidin Sepharose beads (GE) were added the next day, and incubated for another 1 h with the samples. The beads were then collected and washed with binding buffer three times.
The beads were subsequently boiled in 2×laemmli buffer and analyzed by western blotting.
For linear and circular DNA competition assays, the ratios of the non-biotin labeled linear/circular DNA to the biotin DNA duplex were 5:1 or 10:1. Linear DNA was generated by PCR amplification using non-biotin-labeled primers, and circular DNA was obtained by cloning a PCR product into the pCDNA 3.1 plasmid (Invitrogen, USA).
The following sequences were used for PCR: 
Statistical analysis
Statistical analyses were conducted using two-tailed Student's t-test between two groups. All data are presented as mean ± S.D. or mean ± S.E.M. as indicated, and a p value < 0.05 was considered statistically significant. Independent experiments were performed in triplicates.
